(Q43478062)

23 November 2017

title

Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database (English)

1 reference

23 November 2017

0 references

3

1 reference

23 November 2017

Chenwei Wu

1

1 reference

23 November 2017

William J Aronson

2

1 reference

23 November 2017

Joseph C Presti

4

1 reference

23 November 2017

Christopher J Kane

5

1 reference

23 November 2017

Christopher L Amling

6

1 reference

23 November 2017

Stephen J Freedland

7

1 reference

23 November 2017

publication date

10 January 2013

1 reference

23 November 2017

1 reference

23 November 2017

volume

111

1 reference

23 November 2017

issue

8

1 reference

23 November 2017

page(s)

E310-8

1 reference

Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

The influence of hepatic function on prostate cancer outcomes after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

The association of diabetes mellitus and high-grade prostate cancer in a multiethnic biopsy series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Effect of obesity and body fat distribution on sex hormones and insulin in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

High-grade prostate cancer is associated with low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Testosterone as a predictor of pathological stage in clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Prostate cancer: another aspect of the insulin-resistance syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Diabetes mellitus and risk of prostate cancer (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Glycemic status and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

The protective effect of diabetes mellitus against prostate cancer: role of sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Glycemic control and prostate cancer progression: Results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11687.X

10.1111/J.1464-410X.2012.11687.X

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference